Extendicare (TSE:EXE) Upgraded at Cormark
Cormark upgraded shares of Extendicare (TSE:EXE – Free Report) to a moderate buy rating in a report issued on Wednesday morning,Zacks.com reports. Cormark also issued estimates for Extendicare’s FY2024 earnings at $0.79 EPS, FY2025 earnings at $0.74 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $0.95 EPS. EXE has been the topic of […]
Cormark upgraded shares of Extendicare (TSE:EXE – Free Report) to a moderate buy rating in a report issued on Wednesday morning,Zacks.com reports. Cormark also issued estimates for Extendicare’s FY2024 earnings at $0.79 EPS, FY2025 earnings at $0.74 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $0.95 EPS. EXE has been the topic of […]
